Table 2

Reduction (mm Hg) from baseline in diurnal IOP and at 08:00, 12:00 and 16:00, Visits 4–7

LBN 0.006% (n=82)LBN 0.012% (n=85)LBN 0.024% (n=83)LBN 0.040% (n=81)Latanoprost 0.005% (n=82)
Day 7 (Visit 4)
Mean diurnal CFB
 LS mean6.867.678.278.487.29
 Difference (95% CI)−0.43 (−1.33 to 0.47)0.39 (−0.51 to 1.28)0.98 (0.08 to 1.88)1.19 (0.29 to 2.09)
  p Value*0.3520.3980.0330.009
CFB at 08:00
 LS mean7.298.318.768.898.01
 Difference (95% CI)−0.72 (−1.76 to 0.32)0.30 (−0.73 to 1.33)0.75 (−0.28 to 1.78)0.88 (−0.15 to 1.91)
  p Value0.1740.570.1550.095
CFB at 12:00
 LS mean6.697.648.298.337.21
 Difference (95% CI)−0.53 (−1.51 to 0.46)0.43 (−0.55 to 1.40)1.07 (0.10 to 2.05)1.12 (0.14 to 2.10)
  p Value0.2930.3900.0320.026
CFB at 16:00
 LS mean6.637.007.808.266.61
 Difference (95% CI)0.02 (−0.96 to 1.01)0.39 (−0.59 to 1.36)1.19 (0.21 to 2.16)1.65 (0.68 to 2.63)
  p Value0.9630.4330.0170.001
Day 14 (Visit 5)
Mean diurnal CFB
 LS mean7.617.938.868.617.72
 Difference (95% CI)−0.11 (−1.04 to 0.81)0.22 (−0.70 to 1.13)1.14 (0.23 to 2.05)0.89 (−0.03 to 1.80)
  p Value0.8120.6440.0150.057
CFB at 08:00
 LS mean8.348.469.669.048.42
 Difference (95% CI)−0.08 (−1.10 to 0.94)0.04 (−0.96 to 1.04)1.24 (0.24 to 2.24)0.62 (−0.38 to 1.62)
  p Value0.8770.9410.0160.225
CFB at 12:00
 LS mean7.508.388.708.567.52
 Difference (95% CI)−0.02 (−1.08 to 1.05)0.86 (−0.19 to 1.91)1.18 (0.13 to 2.23)1.04 (−0.01 to 2.09)
  p Value0.9720.1070.0280.053
CFB at 16:00
 LS mean7.056.918.318.267.12
 Difference (95% CI)−0.07 (−1.13 to 1.00)−0.22 (−1.27 to 0.84)1.19 (0.14 to 2.25)1.14 (0.08 to 2.19)
  p Value0.9010.6890.0270.034
Day 28 (Visit 6)
Mean diurnal CFB
 LS mean7.818.269.008.937.77
 Difference (95% CI)0.05 (−0.82 to 0.91)0.50 (−0.36 to 1.36)1.23 (0.37 to 2.10)1.16 (0.29 to 2.03)
  p Value0.9130.2580.0050.009
CFB at 08:00
 LS mean8.458.839.599.648.64
 Difference (95% CI)−0.18 (−1.18 to 0.82)0.19 (−0.80 to 1.19)0.96 (−0.04 to 1.95)1.01 (0.00 to 2.01)
  p Value0.7200.7030.0590.049
CFB at 12:00
 LS mean7.838.129.028.747.66
 Difference (95% CI)0.17 (−0.80 to 1.14)0.47 (−0.49 to 1.42)1.36 (0.40 to 2.32)1.08 (0.12 to 2.05)
  p Value0.7300.3400.0060.028
CFB at 16:00
 LS mean7.177.798.598.446.94
 Difference (95% CI)0.23 (−0.71 to 1.17)0.86 (−0.07 to 1.79)1.66 (0.73 to 2.59)1.50 (0.57 to 2.44)
  p Value0.6290.0700.0010.002
Day 29 (Visit 7)
Mean diurnal CFB
 LS mean6.196.177.216.876.25
 Difference (95% CI)−0.07 (−1.03 to 0.90)−0.08 (−1.03 to 0.87)0.95 (−0.00 to 1.91)0.62 (−0.34 to 1.57)
  p Value0.8940.8690.0510.204
CFB at 08:00
 LS mean7.016.757.737.436.94
 Difference (95% CI)0.07 (−1.00 to 1.14)−0.19 (−1.25 to 0.86)0.79 (−0.27 to 1.85)0.48 (−0.58 to 1.54)
  p Value0.8970.7200.1440.369
CFB at 12:00
 LS mean6.036.087.146.916.13
 Difference (95% CI)−0.09 (−1.16 to 0.97)−0.04 (−1.09 to 1.01)1.02 (−0.04 to 2.07)0.79 (−0.27 to 1.84)
  p Value0.8620.9370.0580.144
CFB at 16:00
 LS mean5.475.696.756.115.67
 Difference (95% CI)−0.20 (−1.28 to 0.89)0.02 (−1.03 to 1.08)1.09 (0.03 to 2.14)0.45 (−0.62 to 1.51)
  p Value0.7210.9650.0450.411
  • IOP reduction=IOP value at baseline minus IOP value postbaseline. The reference treatment was latanoprost.

  • *Results obtained from an ANCOVA model with treatment effect and baseline IOP. ANCOVA, analysis of covariance; CFB, change from baseline; IOP, intraocular pressure; LBN, latanoprostene bunod; LS, least squares.